{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:08:52Z","timestamp":1790662132893,"version":"4.1.0"},"reference-count":46,"publisher":"National Academy of Sciences","issue":"8","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2007,2,20]]},"abstract":"<jats:p>\n                    Fabry disease is inherited as an X-linked disorder secondary to deficiency of \u03b1-galactosidase A, resulting in abnormal metabolism of substances containing \u03b1-\n                    <jats:sc>d<\/jats:sc>\n                    -galactosyl moieties. As a consequence, a multisystem disorder develops, culminating in strokes, progressive renal, and cardiac dysfunction. Signs and symptoms of Fabry disease become manifest in childhood, but diagnosis is often delayed. Thirteen children with Fabry disease (age range, 6.5\u201317 years) were studied as part of a 6-month open-label study of enzyme replacement therapy (ERT) with agalsidase alfa. Paired serum samples were drawn at the start of the study and after 6 months of ERT. Global protein changes in paired samples were compared by using differential stable isotope labeling of peptide lysine residues with\n                    <jats:italic>O<\/jats:italic>\n                    -methylisourea and subsequent nanoHPLC\u2013tandem MS. Statistically significant decreases were observed for five proteins following ERT: \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    -HS glycoprotein, vitamin D-binding protein, transferrin, Ig-\u03b1-2 C chain, and \u03b1-2-antiplasmin. The presence of low levels of \u03b1-2-antiplasmin and plasminogen was confirmed by alternate means in 34 consecutive patients, including four of five ERT-na\u00efve subjects. Decreased \u03b1-2-antiplasmin was associated with a parallel increase in circulating VEGF. Soluble VEGF receptor-2 was significantly elevated in plasma of patients compared with pediatric controls and decreased with ERT. These results suggest previously unknown abnormalities of fibrinolysis and angiogenesis factors in Fabry disease. We demonstrated the feasibility of identifying treatment-specific alterations in a small number of subjects that point to previously unsuspected disease-related biological abnormalities.\n                  <\/jats:p>","DOI":"10.1073\/pnas.0611315104","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T20:37:46Z","timestamp":1171485466000},"page":"2873-2878","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":58,"title":["Proteomics of specific treatment-related alterations in Fabry disease: A strategy to identify biological abnormalities"],"prefix":"10.1073","volume":"104","author":[{"given":"David F.","family":"Moore","sequence":"first","affiliation":[{"name":"*Section of Neurology and Section of Proteomics and System Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg V.","family":"Krokhin","sequence":"additional","affiliation":[{"name":"Manitoba Center for Proteomics and System Biology, University of Manitoba, Winnipeg, ON, Canada R3C 4J5; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Beavis","sequence":"additional","affiliation":[{"name":"Manitoba Center for Proteomics and System Biology, University of Manitoba, Winnipeg, ON, Canada R3C 4J5; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ries","sequence":"additional","affiliation":[{"name":"Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1260"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chevalia","family":"Robinson","sequence":"additional","affiliation":[{"name":"Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1260"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Goldin","sequence":"additional","affiliation":[{"name":"Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1260"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roscoe O.","family":"Brady","sequence":"additional","affiliation":[{"name":"Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1260"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Wilkins","sequence":"additional","affiliation":[{"name":"Manitoba Center for Proteomics and System Biology, University of Manitoba, Winnipeg, ON, Canada R3C 4J5; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schiffmann","sequence":"additional","affiliation":[{"name":"Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1260"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2007,2,20]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1898.tb16317.x"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01986897"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196705252762101"},{"key":"e_1_3_4_4_2","first-page":"3733","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Desnick R","year":"2001","unstructured":"R Desnick, YA Ioannou, CM Eng The Metabolic and Molecular Bases of Inherited Disease, eds R Charles, C Scriver, L Arthur, A Beaudet, S William, W Sly, D Valle (McGraw\u2013Hill, 8th Ed, New York), pp. 3733\u20133774 (2001).","edition":"8"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc3801.096352"},{"key":"e_1_3_4_6_2","first-page":"4","volume":"2","author":"Moore D","year":"2002","unstructured":"D Moore, G Altarescu, P Herscovitch, R Schiffmann Biomed Cent Neurol 2, 4 (2002).","journal-title":"Biomed Cent Neurol"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.7.1559"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20162"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi152"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1124619"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/13690"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M400129-MCP200"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac030421"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(84)90077-X"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161206776056038"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1678"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-05-0432"},{"key":"e_1_3_4_20_2","first-page":"385","volume":"22","author":"Pisani A","year":"2005","unstructured":"A Pisani, A Sessa, M Sabbatini, MV Andreucci, C Fusco, M Balletta, B Cianciaruso G Ital Nefrol 22, 385\u2013389 (2005).","journal-title":"G Ital Nefrol"},{"key":"e_1_3_4_21_2","first-page":"475","volume":"16","author":"Rahman P","year":"1998","unstructured":"P Rahman, DD Gladman, J Wither, MD Silver Clin Exp Rheumatol 16, 475\u2013478 (1998).","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063287"},{"key":"e_1_3_4_23_2","first-page":"596","volume":"158","author":"Perrot X","year":"2002","unstructured":"X Perrot, N Nighoghossian, L Derex, M Hermier, N Guffon, J Boulliat, P Trouillas Rev Neurol (Paris) 158, 596\u2013598 (2002).","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2004.05.001"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.10.105"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000209649.60409.38"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-2-1"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000141775.67189.98"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP63146"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000172723.52499.38"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000172719.26606.6f"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh546"},{"key":"e_1_3_4_33_2","first-page":"1096","volume":"24","author":"Moore D","year":"2003","unstructured":"D Moore, F Ye, R Schiffmann, JA Butman Am J Neuroradiol 24, 1096\u20131101 (2003).","journal-title":"Am J Neuroradiol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04880.x"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04881.x"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<65::AID-AJH13>3.0.CO;2-0"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH03-12-0764"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00450a014"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02736753"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200590056"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3218"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2895"},{"key":"e_1_3_4_44_2","volume-title":"The R Reference Manual, Base Package","year":"2004","unstructured":"The R Reference Manual, Base Package (Network Theory Limited, Bristolm, UK) Vols 1 and 2 (2004)."},{"key":"e_1_3_4_45_2","first-page":"735","volume":"24","author":"Dilena BA","year":"1986","unstructured":"BA Dilena, MJ Peake J Clin Chem Clin Biochem 24, 735\u2013740 (1986).","journal-title":"J Clin Chem Clin Biochem"},{"key":"e_1_3_4_46_2","first-page":"561","volume":"52","author":"Vlug A","year":"1994","unstructured":"A Vlug, EJ Nieuwenhuys, RV van Eijk, HG Geertzen, AJ van Houte Ann Biol Clin (Paris) 52, 561\u2013567 (1994).","journal-title":"Ann Biol Clin (Paris)"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.0611315104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T14:39:13Z","timestamp":1649774353000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.0611315104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,20]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,2,20]]}},"alternative-id":["10.1073\/pnas.0611315104"],"URL":"https:\/\/doi.org\/10.1073\/pnas.0611315104","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,20]]},"assertion":[{"value":"2006-07-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-02-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}